It has been reported that the tTG-IgA test has a sensitivity of 78% to 100% and a specificity of 90% to 100% for diagnosing CeD in individuals with a gluten-containing diet [11]. The gene discussed is TGM2; the disease is cranioectodermal dysplasia.